Beyond the PSA: The hidden costs of screening in prostate cancer

Cancer. 2024 Oct 1;130(19):3272-3274. doi: 10.1002/cncr.35474. Epub 2024 Jul 16.

Authors

Chiranjeev Sanyal¹, Meera V Ragavan²

Affiliations

¹ College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.
² Division of Research, Kaiser Permanente, Pleasanton, California, USA.

PMID: 39012908
DOI: 10.1002/cncr.35474

No abstract available

Publication types

Editorial

MeSH terms

Early Detection of Cancer* / economics
Humans
Male
Mass Screening / economics
Mass Screening / methods
Prostate-Specific Antigen* / blood
Prostatic Neoplasms* / blood
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / economics

Substances

Prostate-Specific Antigen